title: New study supports MHRA advice on combined oral contraceptives.
authors.affiliation: Benefit Risk Management Group, Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK Mira.harrison-woolrych@mhra.gsi.gov.uk.
authors.forename: Mira
authors.initials: M
authors.lastname: Harrison-Woolrych
authors.affiliation: Benefit Risk Management Group, Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK.
authors.forename: Jane
authors.initials: J
authors.lastname: Woolley
mesh_terms: D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D054556:Venous Thromboembolism / Q000453:epidemiology*
chemical_list: D003277:Contraceptives, Oral, Combined